Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.50%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.34%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter5.16%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y18.42%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year30.44%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range56.20 - 76.01 Perf YTD9.09%
Dividend0.94 P/FCF- EPS past 5Y- ROI- 52W High-3.91% Beta-
Dividend %1.26% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low29.97% ATR0.88
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)46.67 Volatility0.87% 1.10%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.88 Prev Close74.39
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume9.48M Price73.04
Recom- SMA20-0.48% SMA500.44% SMA2008.61% Volume17,847,730 Change-1.81%
Apr-27-15 02:49PM  Health care, Tesla top Halftime's trades to go at CNBC
11:54AM  Technical Market Outlook: Market Internals Begin to Weaken
10:40AM  Patience Pays Off for 2 Healthcare Picks at Forbes
09:01AM  Five Positions that Got Hedge Funds Moving Last Week
Apr-26-15 10:52AM  U.S. Tech, Dollar & Health Care ETFs To Watch This Week
Apr-24-15 02:45PM  Johnson & Johnsons Revenues Take a Hit with Stronger Dollar
10:37AM  Mylan lowers price for Perrigo
09:38AM  Pisani's market open: Seattle's finest
Apr-23-15 02:01PM  What Are the Conditions of the Mylan-Teva Deal?
02:00PM  The Teva-Mylan Combination: Whats the Rationale?
12:06PM  AQR Capital Enhances Pfizer Holdings by 33%
12:03PM  Rich Pzena hunts for value
12:01PM  Rich Pzena: If rates go up, these stocks could lag
10:13AM  HCA Holdings: What to Expect from 1Q15 May Earnings Release
09:26AM  The Cyclical Aspect of the Labor Market Conundrum
03:06AM  AQR Capital More Than Doubles its Holdings in Gilead Sciences
Apr-22-15 02:33PM  The MylanTeva Deal: Arbitrage Spread Analysis
02:33PM  Teva Pharmaceuticals Makes a Hostile Bid for Mylan
02:24PM  US Equities Headwinds: Earnings and Valuation
01:58PM  ETFs That Outperform in Late Stage, Recession, and Trough
01:57PM  An Investors Key Guide to Business Cycle Investing
Apr-21-15 03:49PM  Medicare Advantage Enrollments Drive Humanas 1Q15 Revenue Growth
03:47PM  What to Expect from Humanas 1Q15 Earnings
11:11AM  No link with autism and MMR vaccine: Study
10:02AM  Earnings not that bad at all: Pro
Apr-20-15 06:07PM  AQR Capital Ups Stake in Johnson and Johnson
04:10PM  UnitedHealth Groups Optum Posts Healthy 1Q15 Operating Earnings
04:07PM  Maverick Capital Decreases Position in Community Health Systems
Apr-17-15 08:04PM  4 ETF Strategists Weigh In On U.S., European Markets at Investor's Business Daily
07:35PM  The Week Ahead: Fake Out or Breakout? at Forbes
02:22PM  Aetnas 1Q15 Revenue: Driven by Government-Sponsored Enrollments
02:22PM  What to Expect from Aetnas 1Q15 Earnings
02:01PM  UnitedHealthcare Adds 1.6 million Enrollments Year-over-Year
02:01PM  Key Takeaways from UnitedHealth Group 1Q15 Earnings
08:51AM  [video]Buy These 4 High-Yield Dividend Stocks to Take Advantage of the Health Care Boom at TheStreet
Apr-16-15 02:12PM  Exciting time for drug breakthroughs: Merck CEO
01:53PM  Need to change the laws on corporate tax: Pfizer CEO
09:20AM  Maverick Capital Eliminates Its Position in AbbVie
09:16AM  Health Insurance Fee May Reduce UnitedHealth Groups 1Q15 Margins
09:16AM  What to Expect from UnitedHealth Groups 1Q15 Earnings Release
09:10AM  How Lucrative Is Mylans Acquisition of Perrigo?
08:30AM  Healthcare ETFs in Focus Post JNJ Earnings Beat - ETF News And Commentary
Apr-15-15 01:15PM  Healthcare Stocks: A Prescription for More Gains? at Investopedia
12:43PM  Expert: Traders Will Make 'A Lot Of Money' From This Market Transition
Apr-14-15 05:43PM  Curing eye disease, and maybe color blindness
01:19PM  Humana CEO: In agreement with Fink
10:39AM  IBM takes medical data to the cloud
03:06AM  Lone Pine Initiates New Position in HCA Holdings
Apr-13-15 11:06AM  Remaining Invested and Going Cyclical
09:01AM  Five Positions That Hurt Hedge Funds the Most Last Week
Apr-09-15 02:26PM  Top trades to go before Thursday's close at CNBC
01:14PM  Get in shape, earn health discounts
11:43AM  Is the Correction in Healthcare Over? at Forbes
08:31AM  Best bets this year? Consumer discretionary, health care:...
Apr-08-15 02:08PM  Top trades to go before the closing bell at CNBC
12:58PM  Top trades for the 2nd half
Apr-07-15 04:50PM  U.S. stocks lower as days gains fizzle at MarketWatch
02:19PM  Sector ETFs And Earnings
01:23PM  New medical coding & billing system
11:10AM  Bio Tech- Support test in play after large reversal pattern
11:00AM  A Small-Cap Sector ETF Dynamo
Apr-06-15 11:07AM  Which Sectors Should You Invest in Now?
10:54AM  Which ETFs Have Changed Their Trends? at Forbes
Apr-04-15 11:07AM  Leading ETFs: Heath Care, Consumer Discretionary, Treasury Bonds at TheStreet
Apr-03-15 07:05PM  Actavis Focuses on Complex Generics and Para IV Filings
02:06PM  Pfizer-Hospira Deal: A Win-Win Situation
10:05AM  Where Does Pfizer Stand Compared to Its Peers?
Apr-02-15 01:06PM  North American Brandss Position of Strength
07:30AM  Healthcare Exposure Lifts Some International ETFs
Apr-01-15 06:04PM  What Are Aetnas Key Risks?
04:05PM  The Fed Effect A Twist in the Tale
02:29PM  Finding winners in the best, worst of 2015 market at CNBC
02:05PM  Why Is Pfizers Revenue Stream Declining?
01:50PM  This Sector Is Dominating The IPO Market In 2015
01:07PM  Utilities vs. health care in April
12:01PM  How to make it rain in April
09:55AM  How You Can Guard Against Volatility
Mar-31-15 09:43PM  Why the stock market is running on empty
04:06PM  Pfizers Global Vaccines, Oncology & Consumer Healthcare Segment
03:11PM  Biotech -Monthly reversal pattern in play at resistance
10:33AM  M&A drivers for 2015
10:14AM  The Bull Case: Supply & Demand Edition
09:45AM  Technical Market Outlook: Breadth, Momentum, Options, & Sectors
08:02AM  Quarter end scorecard
Mar-30-15 06:00PM  What to watch at the end of the quarter
05:06PM  Healthcare ETFs Moving On UnitedHealth Deal
02:06PM  Biopharmaceutical Business: Why Its Important for Pfizer
12:05PM  Must-Know: Aetnas Key Mergers and Acquisitions
10:19AM  These positions hurt hedge funds the most last week
09:06AM  Is the PharmacyclicsAbbVie Merger a Setup?
Mar-28-15 04:05AM  ETFs Capitalize on the Generic Industrys Growth
03:05AM  What Drives Generic Pharmaceuticals Valuation?
02:05AM  Generic Companies Are Fighting for Market Share
02:05AM  Specialty Generics: Why Are They Getting More Attention?
02:05AM  Affordable Pricing Is Driving the Generic Drug Market
02:05AM  How Aetna Generates Value for its Shareholders
01:05AM  Farallon Capital Increases Position in Covidien
01:05AM  The PharmacyclicsAbbVie Merger: What Are the Details?
01:05AM  How Does Aetna Compare with Its Peers in Valuation?
01:05AM  How the NAICs Capital Requirements Affect Aetna
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.